PAR paradigm biopharmaceuticals limited..

The Ghosh Study - PART 1, page-40

  1. 2,022 Posts.
    lightbulb Created with Sketch. 2398
    I honestly don’t think i’ve twisted anything at all. If we’re going by the slides they used to illustrate the full process, it’s clear that NDAs/CDAs are a couple of steps before dataroom access. It’s uncharacteristically bullish of you to suggest all of those companies who signed NDA’s then submitted non-binding offers.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
38.5¢
Change
0.000(0.00%)
Mkt cap ! $153.0M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 7594 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.5¢ 4500 1
View Market Depth
Last trade - 09.45am 31/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.